Grace Kim | executive |
Spiro Rombotis | executive |
Brian Schwartz | executive |
Paul Mcbarron | executive |
Ahu Demir | analyst |
Brian Kemp Dolliver | analyst |
Good afternoon, and welcome to the Cyclacel Pharmaceuticals Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast. [Operator Instructions] Please note, today's call is being recorded. I would now like to turn the conference call over to the company. Please go ahead.
Good afternoon, everyone, and thank you for joining today's conference call to discuss Cyclacel's financial results and business highlights for the fourth quarter and financial year ended December 31, 2023.